| RNTX Shares Outstanding History Table | ||||||||||||||
Below is a table of the RNTX shares outstanding history going back to 11/12/2024:
Also see: RNTX Market Cap History RNTX YTD Return |
As of 5/13/2026 Rein Therapeutics has 85.54 million RNTX shares outstanding. Investors often track the RNTX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RNTX share count trends over time, with 6 historical shares outstanding datapoints presented, dating back to 11/12/2024.

| RNTX Shares Outstanding History Table | ||||||||||||||
Below is a table of the RNTX shares outstanding history going back to 11/12/2024:
Also see: RNTX Market Cap History RNTX YTD Return |
| RNTX Shares Outstanding History Chart | |||||||||||||||
RNTX Historical Shares Outstanding: +150.43% CAGR
Mouse over chart for data details
| |||||||||||||||
| RNTX Stock Price Chart |
| About Rein Therapeutics Inc |
| Aileron Therapeutics, Inc. is a biopharmaceutical company. Co. is advancing a pipeline of medicines to address unmet medical needs in orphan pulmonary and fibrosis indications. Its lead product candidate, LTI-03, is a synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. LTI-03 is being evaluated in a Phase Ib clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its second product candidate, LTI-01, is a proenzyme, or zymogen, designed to slowly activate in the pleural space and break up the scar tissue, allowing for drainage of the pleural effusion. We show 6 historical shares outstanding datapoints in our coverage of RNTX's shares outstanding history. Understanding the changing numbers of RNTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RNTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RNTX by allowing them to research RNTX shares outstanding history as well as any other stock in our coverage universe. |
| RNTX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| RNTX Share Performance |
| Shares Outstanding Peers |
| Rein Therapeutics (RNTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RNXT Shares Outstanding History RPHM Shares Outstanding History RPID Shares Outstanding History RPRX Shares Outstanding History RSLS Shares Outstanding History RTIX Shares Outstanding History RTRX Shares Outstanding History RTTR Shares Outstanding History RUBY Shares Outstanding History RVMD Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.